MedPath

A trial done to determine the amount of air needed to increase the success of passing nasal tube in head and neck cancer patients.

Not Applicable
Conditions
Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2021/07/035217
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Age 18 to 70 years

2)ASA 1 and 2

3)Head and neck cancer surgeries requiring nasotracheal intubation

4)Mouth opening more than 1.5 cm (more than 1 and ½ finger).

Exclusion Criteria

1)Trismus with restricted mouth opening ( <1.5 cm)

2)Total ankyloglossia with a complete involvement of base of tongue in carcinoma tongue

3) BMI more than 35.

4) Patients with severe cardiac disease

5) ASA 3 and above

6) Patients planned for an upfront elective awake Tracheostomy or awake fiberoptic intubation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath